CVS earnings date and last-quarter result: last quarter beat, P/E 46.79. Updated 2026-07-23.
CVS Health (CVS) Research Hub
CVS Health (CVS) trades on NYSE, US in the Healthcare (Medical - Healthcare Plans) sector. As of 2026-10-26, shares last closed at 92.53 USD (-1.01%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 46.79, market cap 138.97B. This hub links to the full technical, earnings and options research available for CVS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Plans) |
|---|---|
| Exchange | NYSE, US |
| Last close | 92.53 USD (-1.01%) |
| 52-week range | 84.23 USD – 110.68 USD |
| Trend regime | Range |
| 14-day RSI | 67.9 (Bullish) |
| Trailing P/E | 46.79 |
| Market cap | 138.97B |
| Dividend yield | 2.46% |
Available research for CVS
Covered Call on CVS: how it works, illustrative setup around the real 92.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CVS: how it works, illustrative setup around the real 92.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CVS: how it works, illustrative setup around the real 92.53 USD price, max profit/loss, breakeven and when to use it. Educational.
CVS technical analysis: range, last 92.53 USD, RSI 67.9, 52w range 84.23 USD–110.68 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CVS in?
CVS Health (CVS) is classified under Healthcare (Medical - Healthcare Plans), listed on NYSE, US.
Is CVS in an uptrend or downtrend?
As of 2026-10-26, CVS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CVS's trailing P/E ratio?
CVS's trailing P/E is 46.79, with a market cap of 138.97B. See the earnings research page for full valuation detail.